Please login to the form below

Not currently logged in
Email:
Password:

Portland Health appoints Alfred Jackson as a partner

He joins the London-headquartered agency from Spectrum

Alfred JacksonUK-headquartered communications agency Portland Health has appointed Alfred Jacskon as a partner, a role that will see him work alongside the wider business and lead its US offerings.

He has over 20 years’ healthcare advocacy and public affairs experience, gained from working both agency-side and for biotech, pharmaceutical and medical device companies.

He said: “The opportunity to help Portland expand its impressive health footprint to the US market is an incredible opportunity.

“The Portland Health team recognise the importance of legislators, regulators and influencers in shaping the course of treatments, issues, companies and organisations in the US.”

In addition to his work in healthcare, Jackson also has broad experience in public affairs and government relations.

David Mackay, US general manager for Portland Health, said: “We are keen to build on the reputation that Portland has earned in the US and Alfred has the perfect mix of agency experience, senior leadership and strategic relationships across the health and government sectors to deepen our offering to US and global clients.

“We’re very excited to welcome Alfred to the Portland team.”

29th August 2017

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Peter Jackson
Rethinking our approach to infectious disease preparedness
The importance of long-term strategic investment to prepare for the next threat that emerges...
New from the PhRMA: Diversity in clinical trials principles summarised
In November 2020, PhRMA announced the first-ever, industry-wide principles on clinical trial diversity. The principles were approved by the PhRMA Boards of Directors and will take effect in April 2021....
New from the FDA: Diversity in clinical trials guidance summarised
In November 2020, the FDA released guidance to enable greater diversity in clinical trials through changes to eligibility criteria, enrolment practices, and trial designs....

Infographics